Multiplex Assay Kit for Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay)

AK155

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-103 95
EDTA plasma(n=5) 92-99 95
heparin plasma(n=5) 91-99 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-105% 78-104% 92-101% 82-102%
EDTA plasma(n=5) 89-101% 80-89% 80-101% 93-101%
heparin plasma(n=5) 89-98% 84-93% 80-99% 91-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:IL26) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Neuroimmunology Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy PubMed: 23177721
Journal of molecular medicine (Berlin, Germany) IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA. pubmed:28879509
The Journal of investigative dermatology Increased interleukin-26 expression promotes Th17 and Th2-associated cytokine production by keratinocytes in atopic dermatitis Pubmed: 31465744
Nature Communications Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway Pubmed: 32041953
METHOD OF MANUFACTURING BISPECIFIC ANTIBODIES, BISPECIFIC ANTIBODIES AND THERAPEUTIC USE OF SUCH ANTIBODIES
Theranostics IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer 33456560
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB695Hu01 Active Interleukin 26 (IL26) Cell culture; Activity Assays.
RPB695Hu01 Recombinant Interleukin 26 (IL26) Positive Control; Immunogen; SDS-PAGE; WB.
PAB695Hu01 Polyclonal Antibody to Interleukin 26 (IL26) WB; IHC; ICC; IP.
MAB695Hu22 Monoclonal Antibody to Interleukin 26 (IL26) WB; IHC; ICC; IP.
SEB695Hu ELISA Kit for Interleukin 26 (IL26) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB695Hu CLIA Kit for Interleukin 26 (IL26) Chemiluminescent immunoassay for Antigen Detection.
LMB695Hu Multiplex Assay Kit for Interleukin 26 (IL26) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.